Risky Business: Evaluating Oocyte Donation

Abstract

Andrea Gurmankin’s (2001) study on the amount and quality of risk information provided to potential oocyte donors is quite interesting and raises some compelling issues. I share her concern about the valididty of th informed consent provided by donors, but I think the issue is worth further elucidation.

Keywords

Informed Concent, Health Law, Oocyte Donation

Publication Date

2001

Document Type

Article

Place of Original Publication

American Journal of Bioethics

Publication Information

1 (4) The American Journal of Bioethics 18 (2001)

This document is currently not available here.

Share

COinS Jessica Wilen Berg Faculty Bio